| Suc-Ala-Glu-Pro-Phe-AMC | C36H41N5O11 | 719.75 | 142997-30-6 | Suc-Ala-Glu-Pro-Phe-AMC |
| Suc-Ala-Glu-Pro-Phe-pNA | C32H38N6O11 | 682.69 | 128802-76-6 | Suc-Ala-Glu-Pro-Phe-pNA |
| Suc-Ala-Leu-Pro-Phe-OH | C27H38N4O8 | 546.62 | 287379-73-1 | Suc-Ala-Leu-Pro-Phe-OH |
| Suc-Ala-Leu-Pro-Phe-AMC | C37H45N5O9 | 703.8 | 142997-31-7 | Suc-Ala-Leu-Pro-Phe-AMC |
| Suc-Ala-Leu-Pro-Phe-pNA | C33H42N6O9 | 666.73 | 128802-78-8 | Suc-Ala-Leu-Pro-Phe-pNA |
| Suc-Ala-Phe-Pro-Phe-pNA | C36H40N6O9 | 700.75 | 128802-73-3 | Suc-Ala-Phe-Pro-Phe-pNA |
| H-D-Ala-Leu-Lys-AMC | C25H37N5O5 | 487.6 | 104881-72-3 | H-D-Ala-Leu-Lys-AMC |
| H-Ala-Phe-Lys-AMC | C28H35N5O5 | 521.62 | 120928-02-1 | H-Ala-Phe-Lys-AMC |
| Boc-Glu-Lys-Lys-AMC | C32H48N6O9 | 660.77 | 73554-85-5 | Boc-Glu-Lys-Lys-AMC |
| Boc-Val-Leu-Lys-AMC | C32H49N5O7 | 615.77 | 73554-84-4 | Boc-Val-Leu-Lys-AMC |
| H-D-Ile-Phe-Lys-pNA | C27H38N6O5 | 526.64 | 76626-41-0 | H-D-Ile-Phe-Lys-pNA |
| Isovaleryl-Phe-Lys-pNA | C26H35N5O5 | 497.56 | 178894-43-4 | Isovaleryl-Phe-Lys-pNA |
| MeOSuc-Ala-Phe-Lys-AMC | C33H41N5O8 | 635.72 | 201853-92-1 | MeOSuc-Ala-Phe-Lys-AMC |
| Suc-Ala-Phe-Lys-AMC | C32H39N5O8 | 621.69 | 73207-91-7 | Suc-Ala-Phe-Lys-AMC |
| Urinary Trypsin Inhibitor Fragment | C40H66N14O9S | 919.12 | 164859-77-2 | H-Arg-Gly-Pro-Cys-Arg-Ala-Phe-Ile-OH |
| H-D-Val-Leu-Lys-AMC | C27H41N5O5 | 515.65 | 148168-23-4 | H-D-Val-Leu-Lys-AMC |
| H-D-Val-Leu-Lys-pNA | C23H38N6O5 | 478.51 | 62354-43-2 | H-D-Val-Leu-Lys-pNA |
| Suc-Ala-Pro-pNA | C18H22N4O7 | 406.4 | 95632-46-5 | Suc-Ala-Pro-pNA |
| Suc-Gly-Pro-AMC | C21H23N3O7 | 429.43 | 80049-85-0 | Suc-Gly-Pro-AMC |
| Z-Ala-Pro-4MβNA | C27H29N3O5 | 475.54 | 74305-55-8 | Z-Ala-Pro-4MβNA |
